$45.92
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.50 | $-0.60 | 16.7 % |
Mar 2024 | 2024-05-07 | $3.26 | $2.51 | 29.9 % |
Dec 2023 | 2024-02-27 | $0.44 | $-0.03 | 1566.7 % |
Sep 2023 | 2023-11-02 | $-0.58 | $-0.70 | 17.1 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $4.17M | $8.00M | -47.9 % |
Mar 2024 | 2024-05-07 | $254.95M | $120.00M | 112.5 % |
Dec 2023 | 2024-02-27 | $60.00M | $40.00M | 50.0 % |
Sep 2023 | 2023-11-02 | $0 | $10.00M | -100.0 % |
Protagonist Therapeutics (PTGX) is scheduled to report earnings on October 31, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.50, which beat the estimate of $-0.60.
The Actual Revenue was $4.2M, which missed the estimate of $8M.
Browse earnings estimates, EPS, and revenue on all stocks.